W.R. Berkley Corp’s NxStage Medical Inc. NXTM Stock Holding History

W.R. Berkley Corp’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,900	Closed	-$135K	–	110
2017 Q3	$135K	Buy	+4,900	New	+$131K	0.02%	76

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

W.R. Berkley Corp's NXTM Position: Q4 2017 in Review

W.R. Berkley Corp sold out of NxStage Medical Inc. (NXTM) in Q4 2017, closing a stake of 4,900 shares — an estimated $135K sold.

W.R. Berkley Corp first reported a position in NXTM in Q3 2017 and held it in 1 quarter. The position peaked at $135K in Q3 2017. 178 funds tracked by Wall St. Rank hold NXTM as of Q4 2017.

W.R. Berkley Corp reported no remaining NxStage Medical Inc. position as of Q4 2017 after selling out during the quarter.
W.R. Berkley Corp sold 4,900 NxStage Medical Inc. shares in Q4 2017, an estimated $135K.
W.R. Berkley Corp first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 1 quarter.
W.R. Berkley Corp's NxStage Medical Inc. position peaked at $135K in Q3 2017.
178 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2017.

Based on W.R. Berkley Corp's 13F filing for Q4 2017, filed 14 Feb 2018.